| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2010 | WO2009117676A3 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 01/07/2010 | WO2009116078A3 Oral dosage form containing a pyridinol derivative |
| 01/07/2010 | WO2009116076A3 Ophthalmic preparation containing a pyridinol derivative |
| 01/07/2010 | WO2009115517A3 Pyridines and pyrazines as inhibitors of pi3k |
| 01/07/2010 | WO2009112691A3 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 01/07/2010 | WO2009110010A3 Oral dosage form comprising amlodipine and olmesartan |
| 01/07/2010 | WO2009103432A3 Covalently binding imaging probes |
| 01/07/2010 | WO2009100419A3 Method for prophylaxis and treatment of equine herpesvirus type 1 infections |
| 01/07/2010 | WO2009092005A3 Methods of generating cardiomyocytes and cardiac progenitors and compositions |
| 01/07/2010 | WO2009090556A3 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors |
| 01/07/2010 | WO2009088549A3 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 01/07/2010 | WO2009073330A3 Novel vaccines against multiple subtypes of influenza virus |
| 01/07/2010 | WO2009073184A8 Compositions for inducing labor and associated methods |
| 01/07/2010 | WO2009071096A3 Combination of medical and physical cooling treatment of ischemic effects |
| 01/07/2010 | WO2009068761A3 Use of purine derivatives for the manufacture of a medicament |
| 01/07/2010 | WO2009066309A3 Process for preparation of omeprazole |
| 01/07/2010 | WO2009066301A3 Methods and compositions for treating pdx virus with tellurium-containing compounds |
| 01/07/2010 | WO2009066299A3 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease |
| 01/07/2010 | WO2009063226A3 Methods relating to breathing disorders |
| 01/07/2010 | WO2009055823A3 Method to predict responsiveness of breast cancer to polyaminetype chemotherapy |
| 01/07/2010 | WO2009046322A3 Compositions and methods for treating neural anoxia and spreading depression |
| 01/07/2010 | WO2009037581A3 Use of vitamin b12 for treatment of mucosal lesions |
| 01/07/2010 | WO2009023059A3 Treatment of viral infections by modulation of host cell metabolic pathways |
| 01/07/2010 | WO2009010770A3 Dry-powder medicament |
| 01/07/2010 | WO2009007536A8 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/07/2010 | WO2009006403A3 Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof |
| 01/07/2010 | WO2008151304A8 Selective inhibitors for cyclin-dependent kinases |
| 01/07/2010 | WO2008149168A8 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 01/07/2010 | WO2008148790A8 Anti -inflammatory substituted cyclobutenedione compounds |
| 01/07/2010 | WO2008147551A8 Methods and compositions for stimulating cells |
| 01/07/2010 | WO2007045116A8 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 01/07/2010 | US20100005545 Compositions and Methods of Using RNA Interference of SCA1-Like Genes for Control of Nematodes |
| 01/07/2010 | US20100005536 Promoter for Introducing a Gene into a Lymphocyte or Blood Cell and Application Thereof |
| 01/07/2010 | US20100004738 Drug delivery coating for use with a medical device and methods of treating vascular injury |
| 01/07/2010 | US20100004628 System for delivering a composition to the nasal membrane and method of using same |
| 01/07/2010 | US20100004458 Process for producing crystal |
| 01/07/2010 | US20100004440 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/07/2010 | US20100004344 Anti-oxidant dietary composition containing fruits and vegetables, method for preparing the same and use of the composition |
| 01/07/2010 | US20100004342 LFA-1 Inhibitors and Use Thereof |
| 01/07/2010 | US20100004341 C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for Therapy of Fibromyalgia |
| 01/07/2010 | US20100004340 Naphthyl(ethyl) acetamides |
| 01/07/2010 | US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| 01/07/2010 | US20100004338 Topical gel composition comprising azelaic acid |
| 01/07/2010 | US20100004337 Electrostatically charged multi-acting nasal application, product, and method |
| 01/07/2010 | US20100004336 comprising L-lysine-d-amphetamine hydrochloride salt; without spiking blood serum concentrations of amphetamine; sustained release; for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability; reducing oral abuse liability |
| 01/07/2010 | US20100004335 Oral preparation for preventing or improving skin dryness |
| 01/07/2010 | US20100004334 Nutritional Compositions Containing Punicalagins |
| 01/07/2010 | US20100004333 Compositions and methods for treating cardiovascular disorders |
| 01/07/2010 | US20100004332 Levodopa Prodrugs, and Compositions and Uses Thereof |
| 01/07/2010 | US20100004331 Antagonists of prostaglandin d2 receptors |
| 01/07/2010 | US20100004330 Anti-oxidative content material used in drink and food manufacturing method |
| 01/07/2010 | US20100004329 Alcohol metabolism enhancer and alcoholic beverage |
| 01/07/2010 | US20100004328 COMPOUND, Alpha1 ADRENERGIC RECEPTOR ANTAGONISTIC AGENT, AND COMPOSITION |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004326 Metabolites of selective androgen receptor modulators and methods of use thereof |
| 01/07/2010 | US20100004325 Use of Baicalein As Prolyl Hydroxylase 2 Inhibitor |
| 01/07/2010 | US20100004323 Promoter construct |
| 01/07/2010 | US20100004322 TCL1 Expression in Chronic Lymphocytic Leukemia (CLL) Regulated by MIR-29 and MIR-181 |
| 01/07/2010 | US20100004321 Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent |
| 01/07/2010 | US20100004320 Pharmaceutical Composition |
| 01/07/2010 | US20100004319 Composition and Method for the Prevention, Treatment and/or Alleviation of an Inflammatory Disease |
| 01/07/2010 | US20100004318 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004317 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/07/2010 | US20100004316 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 01/07/2010 | US20100004315 Biodegradable Cross-Linked Branched Poly(Alkylene Imines) |
| 01/07/2010 | US20100004314 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a polynucleotide |
| 01/07/2010 | US20100004312 Fused cyclic compounds |
| 01/07/2010 | US20100004311 Excitatory amino acid inhibitors for treating sensitive skins |
| 01/07/2010 | US20100004310 Pharmaceutical formulations for the treatment of alzheimer's disease |
| 01/07/2010 | US20100004309 Dietary Compositions and Methods for Protection Against Chemotherapy, Radiotherapy, Oxidative Stress, and Aging |
| 01/07/2010 | US20100004308 Benzofuran-3-yl(indol-3-yl) Maleimides as Potent GSK3 Inhibitors |
| 01/07/2010 | US20100004306 PIGF-1 Assay and kits and components thereof |
| 01/07/2010 | US20100004305 Naphthylmethylimidizoles as therapeutic agents |
| 01/07/2010 | US20100004304 Methods and compositions for the treatment of malignant melanoma, breast, prostate, colon, papillary thyroid and pancreatic cancer |
| 01/07/2010 | US20100004303 Treatment of endocrine dysfunction using iron chelators |
| 01/07/2010 | US20100004302 Methods for Treating Degenerative Diseases/Injuries |
| 01/07/2010 | US20100004301 Benzoxazoles Useful in the Treatment of Inflammation |
| 01/07/2010 | US20100004300 voltage-gated sodium channel inhibitors such as 4-[(3S,3'R)-3-(3,5-dichlorophenyl)-2'-oxo-1,3'-bipyrrolidin-1'-yl)]-N-(thiazol-2-yl)benzenesulfonamide, used for the treatment of neuropathic or inflammatory pain, arthritis, headaches, neuralgia, epilepsy, neurodegenerative or psychiatric disorders |
| 01/07/2010 | US20100004299 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004297 Novel hexafluoroisopropanol derivatives |
| 01/07/2010 | US20100004296 Waterborne topical compositions for the delivery of azelaic acid |
| 01/07/2010 | US20100004295 Hydrazine amide derivative |
| 01/07/2010 | US20100004294 Stable Lozenge Compositions Providing Rapid Release of Nicotine |
| 01/07/2010 | US20100004293 Crystalline forms of aryl-substituted pyrazole-amide compounds |
| 01/07/2010 | US20100004292 Iminooxazolidine Derivatives and Their Use |
| 01/07/2010 | US20100004291 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 01/07/2010 | US20100004289 Substituted butyrophenone derivatives |
| 01/07/2010 | US20100004287 Cyclic Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 01/07/2010 | US20100004286 Novel isoindolinone derivatives having inhibitory activity against t-type calcium channel and method for preparation thereof |
| 01/07/2010 | US20100004285 POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID |
| 01/07/2010 | US20100004284 Novel Heterocyclic Compounds as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 01/07/2010 | US20100004283 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 01/07/2010 | US20100004282 Treatment of antibiotic-resistant bacteria infection |
| 01/07/2010 | US20100004281 Viral inhibitors |
| 01/07/2010 | US20100004280 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 01/07/2010 | US20100004279 Solid medicinal preparation containing mannitol or lactose |
| 01/07/2010 | US20100004278 Dextromethorphan hydrochloride |
| 01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |